1832 Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,823,400
Closed -$253M 912
2024
Q1
$253M Buy
1,823,400
+20,400
+1% +$2.56M 0.15% 63
2023
Q4
$224M Buy
1,803,000
+165,300
+10% +$16.9M 0.32% 65
2023
Q3
$153M Sell
1,637,700
-48,800
-3% -$5.5M 0.22% 79
2023
Q2
$217M Sell
1,686,500
-168,500
-9% -$20.4M 0.26% 65
2023
Q1
$216M Buy
1,855,000
+516,800
+39% +$57.9M 0.31% 55
2022
Q4
$152M Buy
+1,338,200
New +$147M 0.25% 81
2022
Q2
Sell
-939,200
Closed -$119M 885
2022
Q1
$119M Sell
939,200
-385,600
-29% -$42.2M 0.17% 110
2021
Q4
$179M Buy
1,324,800
+306,500
+30% +$44M 0.32% 80
2021
Q3
$138M Buy
+1,018,300
New +$128M 0.26% 98
2020
Q4
Sell
-1,716,000
Closed -$172M 707
2020
Q3
$172M Sell
1,716,000
-77,200
-4% -$8.07M 0.45% 69
2020
Q2
$177M Buy
1,793,200
+455,600
+34% +$40.8M 0.53% 56
2020
Q1
$91.1M Sell
1,337,600
-244,800
-15% -$15.2M 0.33% 78
2019
Q4
$84.3M Buy
1,582,400
+187,600
+13% +$8.9M 0.26% 90
2019
Q3
$50.6M Buy
1,394,800
+563,200
+68% +$21.9M 0.16% 123
2019
Q2
$29.5M Sell
831,600
-294,800
-26% -$9.27M 0.1% 165
2019
Q1
$32.7M Sell
1,126,400
-670,000
-37% -$23.5M 0.11% 155
2018
Q4
$52.4M Buy
1,796,400
+1,730,400
+2,622% +$54.9M 0.21% 98
2018
Q3
$2.36M Buy
+66,000
New +$2.05M 0.01% 370
2014
Q1
Sell
-286,400
Closed -$2.54M 614
2013
Q4
$2.54M Sell
286,400
-2,000
-0.7% -$15.8K 0.01% 349
2013
Q3
$2.03M Hold
288,400
0.01% 309
2013
Q2
$1.62M Buy
+288,400
New +$1.38M 0.01% 336

Other funds holding DXCM

1832 Asset Management's DXCM Position: Q2 2024 in Review

1832 Asset Management sold out of DexCom (DXCM) in Q2 2024, closing a stake of 1,823,400 shares — an estimated $253M sold.

1832 Asset Management first reported a position in DXCM in Q2 2013 and held it in 21 quarters. The position peaked at $253M in Q1 2024. 999 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • 1832 Asset Management reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • 1832 Asset Management sold 1,823,400 DexCom shares in Q2 2024, an estimated $253M.
  • 1832 Asset Management first reported a position in DexCom in Q2 2013 and held it in 21 quarters.
  • 1832 Asset Management's DexCom position peaked at $253M in Q1 2024.
  • 999 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on 1832 Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.